Mavenclad (cladribine) is an oral medication used to treat multiple sclerosis (MS) that flares up from time to time (relapsing forms of MS). It's not a first-choice medication because it can cause many serious side effects, but it might be an option for people who didn't have good results from other MS medications. You only have to take it a few days out of the year, but need to get regular lab work to check your health. It can be very expensive because it's brand only.
Relapsing forms of multiple sclerosis (MS)
Mavenclad (cladribine) is an antimetabolite. It's not fully known how Mavenclad (cladribine) works, but it's thought to treat MS by killing lymphocytes, a type of white blood cell (WBC). Normally, WBCs protect your body from infections. But in people with MS, they can attack your nerves and cause inflammation (swelling). So Mavenclad (cladribine) treats MS by killing these WBCs to protect your nerves.
Source:Â DailyMed
Along with its needed effects, a medicine may cause some unwanted effects. Some side effects will have signs or symptoms that you can see or feel. Your doctor may watch for others by doing certain tests.
Also, because of the way cancer medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer. Discuss these possible effects with your doctor.
Check with your doctor immediately if any of the following side effects occur:
Check with your doctor as soon as possible if any of the following side effects occur:
More common
Skin rash
This medicine may also cause the following side effects that your doctor will watch out for:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
dizziness
general feeling of discomfort or illness
muscle or joint pain
sweating
trouble in sleeping
weakness
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Short treatment, only need to take it about 10 days per year
Taken by mouth, so can be a good option for people who don't like needles
Comes in a special weekly dosing pack with your exact dose, so convenient to take
Not taken regularly, so might be difficult for some people to remember when to take it
Need to get lab work and tests done before, during, and after treatment
More likely to get sick during and after taking this medication
Brand only, so can be expensive
Remember when to go to your lab appointments and to take your Mavenclad (cladribine) at the right time. Use a calendar or other methods to remind you of these dates.
Swallow Mavenclad (cladribine) whole with water. Don't chew this medication. You can take it with or without food.
Don't take Mavenclad (cladribine) at the same time as other medications because it can affect how well other medications work. If you're on other medications, take them at least 3 hours before or after you take Mavenclad (cladribine).
Mavenclad (cladribine) can cause cancer. Only take it out of the blister when you're ready to take it. If you leave the tablet out on a table or if broken pieces fall on the ground, you must clean the area right away with water to prevent children or pets from touching or eating the medication.
Make sure your hands are dry before you take Mavenclad (cladribine) out of the blister. Swallow this medication immediately. Don't hold the tablet in your hands for too long.
It might take 6 months or longer for your WBC count to recover after you stop Mavenclad (cladribine). During this time, you're still at a higher risk of getting sick so make sure to protect yourself by doing things such as washing your hands with soap and water, avoid touching your eyes or mouth with unwashed hands, and getting enough sleep. Let your provider know right away if you feel sick.
Mavenclad (cladribine) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Cancer | History of cancer | Having other conditions that put you at higher risk for cancer | Multiple rounds of Mavenclad (cladribine) treatment less than 2 years apart
Mavenclad (cladribine) can raise your risk of cancer. Your risk is higher if you have certain conditions, such obesity, or if you're taking certain medications, such as hormone therapy. You'll need to get a cancer screening before you start Mavenclad (cladribine). Don't take this medication if you have cancer. Let your provider know if you have a family history of cancer, you might need to switch to a different medication.
Risk factors: Childbearing age and not using effective birth control | Currently pregnant
Mavenclad (cladribine) can cause birth defects in babies born to mothers who take this medication during pregnancy. Take a pregnancy test before starting this medication. Don't take Mavenclad (cladribine) if you're pregnant. If you're of childbearing age or if you have a female partner who is of childbearing age, you and your partner should use effective birth control during and for 6 months after your Mavenclad (cladribine) treatment. If you become pregnant, stop this medication and talk with your provider about other options for your MS.
Risk factors: Multiple treatment courses of Mavenclad (cladribine) | Currently or history of taking other medications that can lower your immune system
Mavenclad (cladribine) can put you at risk for serious infections. It weakens your immune system by lowering your white blood cells (WBCs). You'll need to get blood work before, during, and after treatment with Mavenclad (cladribine) to track your WBCs. If it's too low, you might need to stop treatment until your WBC count goes up to a normal range.
Before starting this medication, you'll also need to check if you have certain infections because some infections might not show noticeable symptoms. Ask your provider for the full list of tests you need to do. Don't take this medication if you have HIV, active tuberculosis (TB), or active hepatitis. Tell your provider if you feel sick before you start or during treatment with Mavenclad (cladribine), you might need to wait until you're fully recovered before starting or continuing this medication.
Mavenclad (cladribine) can lower your counts of red blood cells (RBCs), WBCs, and platelets. You'll need to get blood tests before, during, and after treatment with this medication to monitor your blood cell counts. Let your provider know right away if you experience symptoms of blood problems, such as dizziness, tiredness, weakness, bruising more easily, bleeds that are difficult to stop.
If you ever need a blood transfusion, make sure your provider knows that you're taking or have taken Mavenclad (cladribine). The donated blood might need to be treated with radiation to prevent a serious complication called transfusion-associated graft-versus-host disease. This is a condition where parts of the transfused blood attack your organs.
Mavenclad (cladribine) can cause liver injuries. This can happen as early as weeks after starting this medication. Tell your provider if you experience symptoms of liver problems, such as nausea, vomiting, stomach pain, fatigue, low appetite, or have yellowing skin and dark urine, you might need to stop Mavenclad (cladribine).
Mavenclad (cladribine) is taken by mouth. Your total dose depends on your weight (3.5 mg/kg). This total dose isn't taken all at once, but divided in half and each half taken about 1 year apart. You take the first half of the total dose during the first treatment course. Then, you take the other half of the dose about 1 year later during the second treatment course. Each treatment course is divided into two treatment cycles, about 1 month apart.
The schedule for the total dose of Mavenclad (cladribine) typically looks like this:
First treatment course (1st half of the total dose)
First cycle: Start any time.
Second cycle: Start 23 to 27 days after you finish the first cycle in the first treatment course.
Second treatment course (2nd half of the total dose)
First cycle: Start at least 10 months (43 weeks) after you finish the first treatment course.
Second cycle: Start 23 to 27 days after you finish the first cycle in the second treatment course.
For each cycle, you'll receive your exact dose of Mavenclad (cladribine) in a special package. Typically in each cycle, you take 10 mg to 20 mg by mouth daily for 4 to 5 days. Don't take more than 20 mg per day.
After you finish both treatment courses of Mavenclad (cladribine), don't take this medication for at least 2 years.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Cancer
Human immunodeficiency virus (HIV)
Active long-term infections, such as hepatitis or tuberculosis
Currently pregnant
Child-bearing age (age when you're able to have children) and not planning to use effective birth control during and for 6 months after Mavenclad (cladribine) treatment
Breastfeeding during and for 10 days after the last dose of Mavenclad (cladribine) treatment
Relapsing forms of multiple sclerosis (MS)
Relapsing forms of multiple sclerosis (MS)
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.